| Budget Amount *help |
¥99,800,000 (Direct Cost: ¥99,800,000)
Fiscal Year 2009: ¥19,800,000 (Direct Cost: ¥19,800,000)
Fiscal Year 2008: ¥19,800,000 (Direct Cost: ¥19,800,000)
Fiscal Year 2007: ¥19,800,000 (Direct Cost: ¥19,800,000)
Fiscal Year 2006: ¥19,800,000 (Direct Cost: ¥19,800,000)
Fiscal Year 2005: ¥20,600,000 (Direct Cost: ¥20,600,000)
|
|---|
| Research Abstract |
Anti tumor therapy, which generally applicapable for several tumors, has never established, because of the diversity of distribution and condition of tumor cells or the hurdle of targeted delivery of antitumor drugs. In this study, we established the visualization and quantitative method using bioimaging, which became the foundation for non-invasive analysis of the process or tumor proliferation and metastasis. Furthermore, based on the concept of DDS, we developed the carrier for antitumor drugs or gene medicine and apply them for antitumor therapy.
|
